Growth Metrics

Organogenesis Holdings (ORGO) Long-Term Investments (2016 - 2018)

Organogenesis Holdings has reported Long-Term Investments over the past 3 years, most recently at $316.3 million for Q3 2018.

  • Quarterly results put Long-Term Investments at $316.3 million for Q3 2018, up 1.48% from a year ago — trailing twelve months through Sep 2018 was $316.3 million (up 1.48% YoY), and the annual figure for FY2017 was $312.5 million, up 0.81%.
  • Long-Term Investments for Q3 2018 was $316.3 million at Organogenesis Holdings, roughly flat from $314.8 million in the prior quarter.
  • Over the last five years, Long-Term Investments for ORGO hit a ceiling of $316.3 million in Q3 2018 and a floor of $310.0 million in Q4 2016.
  • Median Long-Term Investments over the past 3 years was $312.1 million (2017), compared with a mean of $312.4 million.
  • Biggest five-year swings in Long-Term Investments: rose 0.81% in 2017 and later rose 1.48% in 2018.
  • Organogenesis Holdings' Long-Term Investments stood at $310.0 million in 2016, then rose by 0.81% to $312.5 million in 2017, then grew by 1.21% to $316.3 million in 2018.
  • The last three reported values for Long-Term Investments were $316.3 million (Q3 2018), $314.8 million (Q2 2018), and $313.2 million (Q1 2018) per Business Quant data.